APRE
Aprea Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD0.82
+0.03 (+3.67%)
Rating:B-
Company Profile
CEO
Oren Gilad
IPO Date
2019-10-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$0.78
Prev. Close
$0.79
Day Low
$0.78
Day High
$0.82
52W Low
$0.55
52W High
$2.22
Market Cap
$0.01B
Volume
0.06M